Ghent University Academic Bibliography

An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework

Miet Vandemaele (UGent) , Michelle Leech, Marianne Aznar, Pierre Blanchard, Josep M Borras, Yolande Lievens (UGent) , Ajay Aggarwal, Banu Atalar, Michael Baumgartl, Jenny Bertholet, et al.

(2026) LANCET ONCOLOGY. 27(3). p.e160-e169

Add to list

Journal Article
A1
open access

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

Renée Bultijnck (UGent) , Mieke Van Hemelrijck, Valerie Fonteyne (UGent) , Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, et al.

(2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 45.

Add to list

Journal Article
A1
open access

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Sebastian M. Christ, Filippo Alongi, Umberto Ricardi, Marta Scorsetti, Lorenzo Livi, Panagiotis Balermpas, Yolande Lievens (UGent) , Pètra Braam, Barbara Alicja Jereczek-Fossa, Karin Stellamans, et al.

(2024) RADIOTHERAPY AND ONCOLOGY. 195.

Add to list

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Stephanie G C Kroeze, Matea Pavic, Karin Stellamans, Yolande Lievens (UGent) , Carlotta Becherini, Marta Scorsetti, Filippo Alongi, Umberto Ricardi, Barbara Alicja Jereczek-Fossa, Paulien Westhoff, et al.

(2023) LANCET ONCOLOGY. 24(3). p.e121-e132

Add to list

Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer : a systematic review

Verane Achard, Marta Bottero, Michel Rouzaud, Andrea Lancia, Marta Scorsetti, Andrea Riccardo Filippi, Ciro Franzese, Barbara Alicja Jereczek-Fossa, Gianluca Ingrosso, Piet Ost (UGent) , et al.

(2020) ACTA ONCOLOGICA. 59(10). p.1224-1234

Add to list

Oligorecurrent prostate cancer limited to lymph nodes : getting our ducks in a row

Andrei Fodor, Andrea Lancia, Francesco Ceci, Maria Picchio, Morten Hoyer, Barbara Alicja Jereczek-Fossa, Piet Ost (UGent) , Paolo Castellucci, Elena Incerti, Nadia Di Muzio, et al.

(2019) WORLD JOURNAL OF UROLOGY. 37(12). p.2607-2613

Add to list

Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study

Thomas Steuber, Cordula Jilg, Pierre Tennstedt, Aurélie De Bruycker, D. Tilki, Karel Decaestecker (UGent) , T. Zilli, Barbara Alicja Jereczek-Fossa, Ulrich Wetterauer, Anca-Ligia Grosu, et al.

(2019) EUROPEAN UROLOGY FOCUS. 5(6). p.1007-1013

Add to list

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer : a multicenter study

Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, Gianluca Ingrosso, Paolo Borghetti, Fabio Trippa, Andrea Lancia, Beatrice Detti, Giulio Francolini, Fabio Matrone, et al.

(2019) WORLD JOURNAL OF UROLOGY. 37(12). p.2631-2637

Add to list

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, Thomas Zilli, Nicholas Van As, Andrei Fodor, Piet Dirix, Alfonso Gomez-Iturriaga, Fabio Trippa, Shankar Siva, et al.

(2019) EUROPEAN UROLOGY. 76(6). p.732-739

Add to list

Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer : single institution series of 94 consecutive patients and 124 lymph nodes

Barbara Alicja Jereczek-Fossa, Giuseppe Fanetti, Cristiana Fodor, Delia Ciardo, Luigi Santoro, Claudia Maria Francia, Matteo Muto, Alessia Surgo, Dario Zerini, Giulia Marvaso, et al.

(2017) CLINICAL GENITOURINARY CANCER. 15(4). p.E623-E632

Academic Bibliography

An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer : a systematic review

Oligorecurrent prostate cancer limited to lymph nodes : getting our ducks in a row

Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer : a multicenter study

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer : single institution series of 94 consecutive patients and 124 lymph nodes

Contents

Support

Contact